This session will teach you how to identify probable market direction 3 days in advance, and it’s already spotted 3 explosive little-known opportunities heating up.
You’ll discover:
How predictive A.I. identifies hidden shifts in market momentum
Why most traders who lose are just using the wrong tools
A framework you can use immediately to spot high-probability setups
This is not theory. You’ll see real stock and options A.I. forecasts and how traders use them in live conditions. Seats are limited because this is interactive training, and registration is filling quickly.
MercadoLibre (MELI) reported earnings of $11.03 per share on revenue of $8.76 billion for the fourth quarter ended December 2025. The consensus earnings estimate was $11.77 per share on revenue of $8.52 billion. The Earnings Whisper number was $12.01 per share. The company missed expectations by 8.16% while revenue grew 44.56% on a year-over-year basis.
Mercadolibre Inc together with its subsidiaries hosts the online commerce platform in Latin America, which is focused on enabling e-commerce and its related services.
Positive Guidance
Clarivate Guides Earnings Above Estimates
Clarivate Plc (CLVT) said it expects 2026 non-GAAP earnings of $0.70 to $0.80 per share on revenue of $2.30 billion to $2.42 billion. The current consensus earnings estimate is $0.67 per share on revenue of $2.39 billion for the year ending December 31, 2026.
Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation.
First Solar Inc (FSLR) said it expects 2026 revenue of $4.90 billion to $5.20 billion. The current consensus revenue estimate is $6.11 billion for the year ending December 31, 2026.
First Solar is a leading global provider of comprehensive photovoltaic solar energy solutions which use its advanced module and system technology. The Company’s integrated power plant solutions deliver an economically attractive alternative to fossil-fuel electricity generation today. From raw material sourcing through end-of-life module recycling, First Solar’s renewable energy solutions protect and enhance the environment.
Supernus Pharmaceuticals (SUPN) reported earnings of $0.75 per share on revenue of $211.57 million for the fourth quarter ended December 2025. The consensus earnings estimate was $0.14 per share on revenue of $196.69 million. The company beat consensus estimates by 435.71% while revenue grew 21.48% on a year-over-year basis.
The company said it expects 2026 revenue of $840.0 million to $870.0 million. The current consensus revenue estimate is $850.57 million for the year ending December 31, 2026.
Supernus Pharmaceuticals Inc., is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases.
Axogen (AXGN) reported a loss of $0.28 per share on revenue of $59.90 million for the fourth quarter ended December 2025. The consensus estimate was a loss of $0.01 per share on revenue of $57.90 million. The company missed consensus estimates by 2,700.00% while revenue grew 21.25% on a year-over-year basis.
The company said it expects 2026 revenue of $265.7 million or more. The current consensus revenue estimate is $257.6 million for the year ending December 31, 2026.
Axogen is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair.
NVIDIA is Expected to Beat Estimates
NVIDIA (NVDA) is confirmed to report earnings on Wednesday, February 25, 2026 at approximately 4:20 PM ET. The consensus earnings estimate is $1.52 per share on revenue of $65.56 billion, respresenting 66.7% year-over-year revenue growth, and the Earnings Whisper ® number is $1.56 per share. Investors are 12.8% bullish going into the company's earnings release.
Supernus Pharmaceuticals (SUPN) reported earnings of $0.75 per share on revenue of $211.57 million for the fourth quarter ended December 2025. The consensus earnings estimate was $0.14 per share on revenue of $196.69 million. The company beat consensus estimates by 435.71% while revenue grew 21.48% on a year-over-year basis.
Axogen (AXGN) reported a loss of $0.28 per share on revenue of $59.90 million for the fourth quarter ended December 2025. The consensus estimate was a loss of $0.01 per share on revenue of $57.90 million. The company missed consensus estimates by 2,700.00% while revenue grew 21.25% on a year-over-year basis.